Christopher J. Senner
CIK 1648367 · EVP and CFO · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$55.94M
Companies
3
Total Filings
73
Lifetime Open-Market Net
-$24.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 5 of 8
73 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-17 | EXEL | Tax (F) | −18,327 | -$340.7K | EDGAR |
| 2021-12-17 | EXEL | Mixed | +14,360 | -$87.2K | EDGAR |
| 2021-11-17 | EXEL | Tax (F) | −57,713 | -$1.04M | EDGAR |
| 2021-10-04 | EXEL | Mixed | +23,994 | -$176.9K | EDGAR |
| 2021-09-23 | EXEL | Mixed | +34,943 | -$789.9K | EDGAR |
| 2021-06-17 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-05 | EXEL | Grant (A) | +64,150 | $0 | EDGAR |
| 2021-02-17 | EXEL | Tax (F) | −4,105 | -$89.9K | EDGAR |
| 2021-02-05 | EXEL | Mixed | +50,950 | -$410.7K | EDGAR |
| 2021-01-14 | EXEL | Mixed | — | -$640.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.